
R1 RCM RCM
Quarterly report 2022-Q1
added 12-16-2023
R1 RCM DPO Ratio 2011-2026 | RCM
Annual DPO Ratio R1 RCM
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.63 | 6.86 | 5.56 | 4.05 | 6.64 | 14.5 | 11.5 | 25 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25 | 4.05 | 9.97 |
Quarterly DPO Ratio R1 RCM
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.96 | - | 6.53 | 6.96 | 7 | - | 8.22 | 9 | 8.09 | - | 7.62 | 7.49 | 5.79 | - | 4.12 | 4.76 | 5.62 | - | 5.88 | 6.82 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9 | 4.12 | 6.66 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
American Well Corporation
AMWL
|
10.4 | $ 5.46 | -0.91 % | $ 87.6 M | ||
|
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
112 | - | - | $ 102 M | ||
|
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | ||
|
Akerna Corp.
KERN
|
89.4 | - | - | $ 161 M | ||
|
HealthStream
HSTM
|
26.3 | $ 22.0 | -0.23 % | $ 668 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | ||
|
Evolent Health
EVH
|
27 | $ 3.58 | 0.7 % | $ 335 M | ||
|
HealthEquity
HQY
|
47.8 | $ 83.61 | 3.03 % | $ 7.15 B | ||
|
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | ||
|
Omnicell
OMCL
|
27.6 | $ 40.9 | -1.53 % | $ 1.88 B | ||
|
GoodRx Holdings
GDRX
|
191 | $ 2.29 | 5.05 % | $ 883 M | ||
|
Health Catalyst
HCAT
|
19.9 | $ 1.97 | 1.03 % | $ 119 M | ||
|
Progyny
PGNY
|
171 | $ 17.57 | -1.26 % | $ 1.51 B | ||
|
Premier
PINC
|
28.6 | - | - | $ 2.33 B | ||
|
Teladoc Health
TDOC
|
19.2 | $ 5.18 | 0.88 % | $ 913 M | ||
|
10x Genomics
TXG
|
32.5 | $ 22.15 | -0.98 % | $ 2.6 B | ||
|
Veeva Systems
VEEV
|
19.7 | $ 201.0 | 6.64 % | $ 32.3 B | ||
|
SCWorx Corp.
WORX
|
43.2 | $ 0.13 | -2.08 % | $ 190 K | ||
|
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | ||
|
OptimizeRx Corporation
OPRX
|
24.1 | $ 7.93 | 0.7 % | $ 136 M | ||
|
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | ||
|
Phreesia
PHR
|
57.8 | $ 12.79 | 1.35 % | $ 698 M | ||
|
Schrödinger
SDGR
|
35.6 | $ 12.96 | -1.22 % | $ 952 M | ||
|
Zhongchao
ZCMD
|
32 | $ 1.8 | 7.78 % | $ 9.37 M | ||
|
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M |